Marie Morille

Marie Morille (ORCID ; Google Scholar) is Professor of Pharmaceutical Technology and Drug Delivery at the University of Montpellier and the Institute of Regenerative Medicine and Biotherapies (IRMB, INSERM U1183) where she leads NanoEve, a multidisciplinary team exploring the therapeutic potential of both natural nanoparticles (extracellular vesicles (EVs), and synthetic nanocarriers to develop innovative biotherapies. The team investigates the fundamental mechanisms underlying MSC-derived EV activity, develops rational surface-engineering strategies to boost EVs and synthetic nanocarriers therapeutic potential, and translates these approaches toward preclinical and clinical applications, with a particular focus on osteoarthritis and systemic sclerosis. To support the development and clinical translation of these advanced therapies, she also directs the OBBI Integrator (US63 INSERM), a structure dedicated to the bioproduction and characterization of EVs and organoids.